| |
|
|
|
Viking Thera  
|
|
6.5 -0.17 (-0.03%) |
09-28 16:00 |
|
Open: |
6.62 |
Pre close: |
6.67 |
Target:
|
7.80 
|
|
High: |
6.63 |
Low: |
6.48 |
Resistance:
|
6.68
7.20
|
|
Volume: |
480,927 |
Market Cap: |
508M |
Support:
|
5.84
4.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.53
 |
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
6.60 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
6.05 |
Stochastic Oscillator |
%K(14,3):
|
43.33 |
|
MA(250): |
6.29 |
%D(3): |
36.65 |
|
Average Volume(K) |
3-Month: |
2725299
|
52-Week |
High:
|
10.09 |
|
10-Days: |
62436 |
Low: |
4.95 |
|
RSI |
RSI(14):
|
51.95 |
Change(%): |
11.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.600 |
Return on Equity (ttm) |
-17.3 |
Shares Out. (M) |
78.10 |
|
EPS Est. Current Year |
-0.830 |
Return on Assets (ttm) |
-10.9 |
Shares Float (M) |
61.38 |
|
EPS Est. Next Year |
-0.800 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.11 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
54.03 |
|
Forward EPS |
-0.360 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
10150 |
|
Book Value (p.s.) |
3.070 |
EBITDA (p.s.) |
0.000 |
P/E |
-10.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.12 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.35 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.15 |
P/CF |
-17.91 |
|
|
|
|
|
|
